Acquisitions & Agreements
Acquisitions & Agreements
• drkoop.com, the Internet healthcare portal led by Dr. C. Everett Koop, former U.S. Surgeon General, has announced a partnership with Health Resources Publishing (HRP) for HRP’s pharmacy newsletters to feature information provided by drkoop.com.
• MedEra Life Science (Vancouver) and Ericsson Communications (Montreal), have formed a strategic alliance to develop an Internet-based health and healing information center, to be called medbroadcast.com, and other e-medicine initiatives. The agreement could be worth up to $4 million during the first year. Ericsson will provide the technical project design and management, overall site architecture, advertising module development, e-commerce, pharmaceutical and content engines, as well as strategies for scalability, storage and delivery, and systems for international live event transmission. MedEra will compensate Ericsson through a combination of cash and convertible debt.
• NDC Health Information Services ( Atlanta) has established a partnership with Standard Register (Dayton, OH) to provide customers using its pharmacy systems with a selection of business products. Pharmacies using NDC software solutions will receive a Standard Register catalog offering customized forms, labels and a variety of business supplies needed for pharmacy operations.
• Orchid Biocomputer (Princeton, NJ) and the Univer sity of Washington School of Medicine (Seattle) have entered into an agreement to establish a new high-throughput SNP genotyping facility to focus on the determination of human genetic variability and its impact on disease onset and response to drug treatment. This effort will be managed at the university’s new Institute for Quantitative Systems Biology. The new center will be among the first to use Orchid’s new SNP stream, an automated genotyping system that will enable researchers to score up to 30,000 genotypes per day for pharmacogenetic analysis of clinical samples. The company expects to widely release the system.
• Velos Medical Informatics (Fremont, CA) and Prostagen (Allendale, NJ) have signed an agreement to distribute Velos’s disease management software and information products in the prostate cancer market. Velos becomes Prostagen’s disease management software arm, and Prostagen becomes Velos’ distribution and commercialization partner for Velos software and information products for use in prostate cancer. Velos designs, develops and markets disease management software for the renal disease/dialysis, transplantation, oncology, cardiology and cardiothoracic surgery markets. Velos software features a variety of applications, such as patient care, clinical outcomes, scheduling, clinical research and case management.
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.